首页> 外文期刊>European Spine Journal >A randomised controlled trial on the effectiveness of bracing patients with idiopathic scoliosis: failure to include patients and lessons to be learnt
【24h】

A randomised controlled trial on the effectiveness of bracing patients with idiopathic scoliosis: failure to include patients and lessons to be learnt

机译:特发性脊柱侧弯矫正术的有效性随机对照试验:未能纳入患者和需要学习的经验

获取原文
获取原文并翻译 | 示例
           

摘要

Trials often do not succeed in including as many patients as anticipated beforehand. The aim of this paper was to describe why we were not able to include more than a few patients in our randomized controlled treatment trial on the effectiveness of bracing patients with idiopathic scoliosis, and to describe which lessons can be learnt. A pilot study on the willingness to participate in such a trial was conducted amongst 21 patients and their parents. A description of how we prepared and designed this trial, the problems we faced and how we tried to improve the inclusion are given. A total of four patients were included, and 14 refused to participate in an 18-month period. There were a lot less eligible patients than anticipated (40 instead of 100 per year), and the patients’ participation rate was much lower than we had found in our pilot study (21% instead of 70%). The trial failed to include more than a few patients because of an overestimation of the number of eligible patients and because a lot less eligible patients were willing to participate compared to our pilot study. One reason for a low participation rate could be that this trial evaluated a frequently used existing treatment instead of a new treatment, and patients and parents might be afraid of not being treated (despite an intensive secure system for the control arm).
机译:试验通常无法成功地使患者人数超出预期。本文的目的是描述为什么在随机对照治疗试验中我们不能包括多名患者,以支持特发性脊柱侧凸患者的有效性,并描述可以学习的课程。在21名患者及其父母中进行了一项参与此项试验的意愿的初步研究。给出了关于我们如何准备和设计该试验,我们面临的问题以及我们如何尝试改善收录率的描述。总共包括4位患者,其中14位在18个月内拒绝参加。合格患者的数量比预期的要少得多(每年40位,而不是100位),并且患者的参与率比我们在先导研究中发现的要低得多(21%而不是70%)。由于高估了合格患者的数量,并且与我们的先导研究相比,该患者愿意参加的患者少得多,因此该试验未能包括更多的患者。参与率低的一个原因可能是该试验评估了一种常用的现有治疗方法而不是一种新的治疗方法,并且患者和父母可能害怕不接受治疗(尽管对照组使用了强化的安全系统)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号